Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing:

Pierre-Marie Roy, MD, PhD; Emilie Friou, MD; Boris Germeau, MD; Delphine Douillet, MD; Jeffrey Allen Kline, MD, PhD; Marc Righini, MD, PhD; Grégoire Le Gal, MD, PhD; Thomas Moumneh, MD; Andrea Penaloza, MD, PhD

3 March, 2021

NZ Respiratory Research Review Issue 190

Risk of active tuberculosis in migrants diagnosed with cancer: a retrospective cohort study in British Columbia, Canada :

Divjot S Kumar, Lisa A Ronald, Kamila Romanowski, Caren Rose, Hennady P Shulha, Victoria J Cook, James C Johnston

2 March, 2021

NZ Respiratory Research Review Issue 187

Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial:

Roham T. Zamanian, David Badesch, Lorinda Chung, Robyn T. Domsic, Thomas Medsger, Ashley Pinckney, Lynette Keyes-Elstein, Carla D’Aveta, Meagan Spychala, R. James White, Paul M. Hassoun, Fernando Torres, Andrew J. Sweatt, Jerry A. Molitor, Dinesh Khanna, Holden Maecker, Beverly Welch, Ellen Goldmuntz, and Mark R. Nicolls; on behalf of the NIH ASC01 Study Group

2 March, 2021

NZ Respiratory Research Review Issue 190

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease:

Pierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, Sophie Ramel, Isabelle Danner-Boucher, Anne Prevotat, Dominique Grenet, Christophe Marguet, Martine Reynaud-Gaubert, Julie Macey, Laurent Mely, Annlyse Fanton, Sébastien Quetant, Lydie Lemonnier, Jean-Louis Paillasseur, Jennifer Da Silva, and Clémence Martin; for the French Cystic Fibrosis Reference Network Study Group

18 February, 2021

NZ Respiratory Research Review Issue 191

Survival and quality of life after early discharge in low-risk pulmonary embolism:

Stefano Barco, Irene Schmidtmann, Walter Ageno, Toni Anušić, Rupert M. Bauersachs, Cecilia Becattini, Enrico Bernardi, Jan Beyer-Westendorf, Luca Bonacchini, Johannes Brachmann, Michael Christ, Michael Czihal, Daniel Duerschmied, Klaus Empen, Christine Espinola-Klein, Joachim H. Ficker, Cândida Fonseca, Sabine Genth-Zotz, David Jiménez, Veli-Pekka Harjola, Matthias Held, Lorenzo Iogna Prat, Tobias J. Lange, Mareike Lankeit, Athanasios Manolis, Andreas Meyer, Thomas Münzel, Pirjo Mustonen, Ursula Rauch-Kroehnert, Pedro Ruiz-Artacho, Sebastian Schellong, Martin Schwaiblmair, Raoul Stahrenberg, Luca Valerio, Peter E. Westerweel, Philipp S. Wild, Stavros V. Konstantinides on behalf of the HoT-PE Investigators

4 February, 2021

NZ Respiratory Research Review Issue 183

Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism:

Luca Valerio, MD Stefano Barco, MD Marius Jankowski Stephan Rosenkranz, MD Mareike Lankeit, MD Matthias Held, MD Felix Gerhardt, MD Leonhard Bruch, MD Ralf Ewert, MD Martin Faehling, MD Julia Freise, MD Hossein-Ardeschir Ghofrani, MD Ekkehard Grünig, MD Michael Halank, MD Marius M. Hoeper, MD Frederikus A. Klok, MD Hanno H. Leuchte, MD Eckhard Mayer, MD F. Joachim Meyer, MD Claus Neurohr, MD Christian Opitz, MD Kai-Helge Schmidt, MD Hans-Jürgen Seyfarth, MD Franziska Trudzinski, MD Rolf Wachter, MD Heinrike Wilkens, MD Philipp S. Wild, MD Stavros V. Konstantinides, MD

3 February, 2021

NZ Respiratory Research Review Issue 190

‘If not TB, what could it be?’ Chest X-ray findings from the 2016 Kenya Tuberculosis Prevalence Survey:

Brenda Nyambura Mungai, Elizabeth Joekes, Enos Masini, Angela Obasi, Veronica Manduku, Beatrice Mugi, Jane Ong’angò, Dickson Kirathe, Richard Kiplimo, Joseph Sitienei, Rose Oronje, Ben Morton, Stephen Bertel Squire, Peter MacPherson, IMPALA Consortium

27 January, 2021

NZ Respiratory Research Review Issue 187

Pirfenidone plus inhaled N-acetylcysteine for idiopathic pulmonary fibrosis: a randomised trial:

Susumu Sakamoto, Kensuke Kataoka, Yasuhiro Kondoh, Motoyasu Kato, Masaki Okamoto, Hiroshi Mukae, Masashi Bando, Takafumi Suda, Kazuhiro Yatera, Yoshinori Tanino, Tomoo Kishaba, Noboru Hattori, Yoshio Taguchi, Takefumi Saito, Yasuhiko Nishioka, Kazuyoshi Kuwano, Kazuma Kishi, Naohiko Inase, Shinichi Sasaki, Hajime Takizawa, Takeshi Johkoh, Fumikazu Sakai, Sakae Homma the Diffuse Lung Diseases Research Group of the Ministry of Health, Labour and Welfare, Japan

5 January, 2021

NZ Respiratory Research Review Issue 189

Risk Factors, Management, and Outcomes of Legionella Pneumonia in a Large, Nationally Representative Sample:

Joshua Allgaier, DO Tara Lagu, MD, MPH Sarah Haessler, MD Peter B. Imrey, PhD Abhishek Deshpande, MD, PhD Ning Guo, MS Michael B. Rothberg, MD, MPH

19 December, 2020

NZ Respiratory Research Review Issue 196

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial:

Tracey A Day, PhD Adam Penn-Nicholson, PhD Angelique Kany Kany Luabeya, MBChB Andrew Fiore-Gartland, PhD Nelita Du Plessis, PhD Andre G Loxton, PhD Julie Vergara, BA Tom A Rolf, BS Tim D Reid, MSc Asma Toefy, BSc Justin Shenje, MBChB Hendrik Geldenhuys, MBChB Michele Tameris, MBChB Simbarashe Mabwe, MSc Nicole Bilek, PhD Prof Linda-Gail Bekker, MD Andreas Diacon, MD Prof Gerhard Walzl, MD Jill Ashman, MS Aude Frevol, RN Zachary K Sagawa, MS Cecilia Lindestam Arlehamn, PhD Alessandro Sette, PhD Steven G Reed, PhD Rhea N Coler, PhD Prof Thomas J Scriba, PhD Prof Mark Hatherill, MD the TBVPX-203 study team

8 December, 2020

NZ Respiratory Research Review Issue 187